ranQ
ranQ
ranQ
DirectoryIndustriesPlacesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The leading AI company directory, built to boost AI visibility.

DEENFRIT
Product
  • Pricing
  • Directory
  • Industries
  • Trust Score
Company
  • About
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint745,701 companies indexed · Last updated: today
DirectoryIndustryPharmaceutical IndustryWinterthurTrias Pharma GmbH
Trias Pharma GmbH Logo
Verified· 2 sourcesTrust Score
Summary

About the company

The core activity of Trias Pharma GmbH is the development and manufacture of solid dosage forms, in particular oral dosage forms such as tablets and soft capsules, as well as the provision of analytical support services and expertise in the field of drug development, including the development of medical cannabis.

AI-generated
Offering

Products & services

Industry:Pharmaceutical Industry
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
4.1/5

Trias Pharma GmbH

✓ Offered
8
CMC consulting for formulation and analytical development
CMC consulting for formulation, analytical development and documentation of solid dosage forms up to submission; including patent landscape, regulatory assessment, on-site support and third-party management.
Sourcing and management of CMOs
Identification and evaluation of CMOs, benchmarking, RFQ management, coordination of the involved parties, as well as project structure and reporting for development and manufacturing projects.
CMC writing
Preparation of development reports and CTD modules for IND/IMPD files as well as for registration dossiers; based on formulation and analytical development experience.
Troubleshooting for dosage forms
Analysis and problem solving for softgel capsules and solid dosage forms based on document review as well as analytical and manufacturing-technical aspects.
Development of tablets and hard capsules
Formulation concepts, process know-how and development of immediate-release and modified-release forms up to MUPS; including direct compression, wet and dry agglomeration and film coating.
Softgel capsule development
Development of softgel capsules from concept to final product; know-how regarding excipients, formulations, process development and regulatory aspects, as well as documentation and risk assessment.
Development of medical cannabis
Pharmaceutical support for medical cannabis, transition to standardized cannabis medicines, as well as development of oral and pulmonary dosage forms and inhalation devices.
Analytical development
Analytical development for complex dosage forms, in particular softgel capsules and modified-release tablets; method selection, solution development, validation and partner laboratory networking.
Trust & reputation

ranQ Trust Score of Trias Pharma GmbH: 4.1 out of 5.0

Trust Score4.1/ 5.0

High

x

Data basis 54% · As of October 2026

Without public customer reviews the score stays capped.

Trias Pharma GmbH has no value in the Reputation area of the ranQ Trust Score because no data is available. The area carries 42% of the weighting and drops out of the calculation for this profile; it does not lower the score, only the reported data basis.
x
CriterionValueWeight
  • Review quality: No data point — the criterion is taken out of the weighting and does not lower the score.—24%
  • Review volume: No data point — the criterion is taken out of the weighting and does not lower the score.—10%
  • Review recency: No data point — the criterion is taken out of the weighting and does not lower the score.—8%
Trias Pharma GmbH scores 77.2 out of 100 points in the Substance area of the ranQ Trust Score. This area carries 28% of the weighting.
x
CriterionValueWeight
  • Establishment: Years since founding or brand launch, logarithmic. The maximum is reached at 15 years.86.512%
  • Company size: The headcount band, researched by ranQ or stated by the company. It is scored in steps rather than by head count, because the data only provides bands.55.07%
Trias Pharma GmbH scores 83.3 out of 100 points in the Identity area of the ranQ Trust Score. This area carries 22% of the weighting.
x
CriterionValueWeight
  • Verification: Official register entry (commercial register with UID or professional-body record, 55 points), confirmed domain (20 points) and confirmed ranQ profile (up to 25 points, depending on completeness).83.322%
Trias Pharma GmbH scores 11.7 out of 100 points in the Visibility area of the ranQ Trust Score. This area carries 8% of the weighting.
x
CriterionValueWeight
  • Website authority: Ahrefs' Domain Rating measures, on a scale of 0 to 100, how strongly a website is linked from other websites. For Swiss SMEs the range up to 40 is typical; the maximum is reached at 35.11.74%
  • Media authority: No data point — the criterion is taken out of the weighting and does not lower the score.—4%
Qualifications+0.00

Trias Pharma GmbH reaches a ranQ Trust Score of 4.1 out of 5.0 — rated «High». No public customer reviews are available for this provider; the rating is based on the remaining criteria. The data basis is 54%, so the score is backed by part of the criteria. As of October 2026.

The Trust Score cannot be bought and is calculated from publicly verifiable data.

Knowledge

No knowledge articles yet

Once Trias Pharma GmbH has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

Trias Pharma GmbH in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank Trias Pharma GmbH by reviews, experience and specialisations.

Is this your company?

Claim the company profile of Trias Pharma GmbH to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Technoparkstrasse 2
8406 Winterthur

At a glance

Legal form
Limited Liability Company
UID
CHE-419.005.645
Founded
2016 · 10 years
Last commercial register change
January 28, 2026
Employees
1 to 10
Legal form: Graded by liability and disclosure. The weight is kept small: a sole proprietorship is not a dubious company, it is just liable differently.
88.0
6%
  • Branch offices: Branch offices linked in the commercial register. Having none is normal and costs no points.70.03%
    • Full methodology

    Similar companies

    WG
    Widalia GmbH
    Zurich
    MA
    Medropharm AG
    Zurich
    SP
    swisscann pharma GmbH
    Zurich
    ST
    swisscann tec AG
    Zurich
    IS
    IMCD Switzerland AG
    Zurich
    SP
    steinberg pharma ag
    Winterthur
    SG
    SALUVIVO GmbH
    Zurich
    AH
    AeoniQ Holding AG
    Schlieren